Search by Drug Name or NDC
NDC 50632-0001-02 JYNNEOS 50000000 1/.5mL Details
JYNNEOS 50000000 1/.5mL
JYNNEOS is a SUBCUTANEOUS INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Bavarian Nordic A/S. The primary component is VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN.
MedlinePlus Drug Summary
Why get vaccinated? Smallpox/Monkeypox vaccine can prevent infection with some types of orthopox viruses including Smallpox, Monkeypox, and Vaccinia viruses. Smallpox infection can cause a serious illness characterized by rash and fever that may result in death, for some. Monkeypox infection can cause an illness similar to Smallpox. Although generally milder, it can still cause death. Vaccinia virus infection can occur after someone is exposed to a person or an animal who has been exposed to the virus. It generally causes a self-limiting illness.
Related Packages: 50632-0001-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Smallpox/Monkeypox Vaccine
Product Information
| NDC | 50632-0001 |
|---|---|
| Product ID | 50632-001_852e6c10-2932-4263-a658-8011aec61dfc |
| Associated GPIs | 17100084101820 |
| GCN Sequence Number | 081358 |
| GCN Sequence Number Description | smallpox and mpox live vacc/PF VIAL 0.5X10EXP8 SUBCUT |
| HIC3 | W7B |
| HIC3 Description | VIRAL/TUMORIGENIC VACCINES |
| GCN | 48442 |
| HICL Sequence Number | 046759 |
| HICL Sequence Number Description | SMALLPOX AND MPOX VACCINE, LIVE, NONREPLICATING/PF |
| Brand/Generic | Brand |
| Proprietary Name | JYNNEOS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SUSPENSION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 50000000 |
| Active Ingredient Units | 1/.5mL |
| Substance Name | VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN |
| Labeler Name | Bavarian Nordic A/S |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125678 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50632-0001-02 (50632000102)
| NDC Package Code | 50632-001-02 |
|---|---|
| Billing NDC | 50632000102 |
| Package | 20 VIAL in 1 CARTON (50632-001-02) / .5 mL in 1 VIAL (50632-001-01) |
| Marketing Start Date | 2021-03-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |